Page 277 - ILAE_Lectures_2015

5. SMITH D, DEFALLA BA, CHADWICK DW. The misdiagnosis of epilepsy and the management of refractory
epilepsy in a specialist clinic. QJM 1999; 92: 15-23.

6. BENBADIS SR, AGRAWAL V, TATUM WO 4th. How many patients with psychogenic nonepileptic seizures
also have epilepsy? Neurology 2001; 57: 915-917.

7. MARI F, DI BONAVENTURA C, VANACORE N et al. Video-EEG study of psychogenic nonepileptic
seizures: differential characteristics in patients with and without epilepsy. Epilepsia 2006; 47 Suppl 5: 64-67.

8. PLUG L, SHARRACK B, REUBER M. Conversation analysis can help to distinguish between epilepsy and
non-epileptic seizure disorders: a case comparison. Seizure 2009; 18: 43-50.

9. WINSTON GP, MICALLEF C, KENDELL BE et al. The value of repeat neuroimaging for epilepsy at a tertiary
referral centre: 16 years of experience. Epilepsy Res 2013; 105: 349-355.

10. BIEN CG, BAUER J. Autoimmune epilepsies. Neurotherapeutics 2014; 11: 311-318.
11. SAZGAR M, BOURGEOIS BF. Aggravation of epilepsy by antiepileptic drugs. Pediatr Neurol 2005; 33: 227-

234.
12. LLOYD A, McINTOSH E, PRICE M. The importance of drug adverse effects compared with seizure control for

people with epilepsy: a discrete choice experiment. Pharmacoeconomics 2005; 23: 1167-1181.
13. BARKER-HALISKI M, SILLS GJ, WHITE HS. What are the arguments for and against rational therapy for

epilepsy? Adv Exp Med Biol 2014; 813: 295-308.
14. BRIGO F, AUSSERER H, TEZZON F, NARDONE R. When one plus one makes three: the quest for rational

antiepileptic polytherapy with supraadditive anticonvulsant efficacy. Epilepsy Behav 2013; 27: 439-442.
15. FISHER RS, VELASCO AL. Electrical brain stimulation for epilepsy. Nat Rev Neurol 2014; 10: 261-270.
16. KANNER AM, SCHACHTER SC, BARRY JJ et al. Depression and epilepsy: epidemiologic and neurobiologic

perspectives that may explain their high comorbid occurrence. Epilepsy Behav 2012; 24: 156-168.
17. KANNER AM. The treatment of depressive disorders in epilepsy: what all neurologists should know. Epilepsia

2013; 54 Suppl 1: 3-12.
18. LOUGHMAN A, BOWDEN SC, D’SOUZA W. Cognitive functioning in idiopathic generalised epilepsies: a

systematic review and meta-analysis. Neurosci Biobehav Rev 2014; 43: 20-34.
19. ZEMAN A, BUTLER C, MUHLERT N, MILTON F. Novel forms of forgetting in temporal lobe epilepsy.

Epilepsy Behav 2013; 26: 335-342.
20. HOLMES GL. EEG abnormalities as a biomarker for cognitive comorbidities in pharmacoresistant epilepsy.

Epilepsia 2013; 54 Suppl 2: 60-2.
21. EDDY CM, RICKARDS HE, CAVANNA AE. The cognitive impact of antiepileptic drugs. Ther Adv Neurol

Disord 2011; 4: 385-407.
22. BRODIE MJ, MINTZER S, PACK AM, GIDAL BE, VECHT CJ, SCHMIDT D. Enzyme induction with

antiepileptic drugs: cause for concern? Epilepsia 2013; 54: 11-27.
23. BELCASTRO V, D'EGIDIO C, STRIANO P, VERROTTI A. Metabolic and endocrine effects of valproic acid

chronic treatment. Epilepsy Res 2013; 107: 1-8.